Vasculitis refers to a group of disorders that cause inflammation in your blood vessels. It’s also called angiitis or arteritis. It can cause your blood vessels to become weak, dilated, enlarged, or constricted. Damage to organs and tissues may occur if blood flow is restricted.
Vasculitis has several subtypes, most of which are infrequent. One or more organs may be impacted by vasculitis. Long-term or transient conditions are also possible. Although vasculitis may affect anyone, some forms are more prevalent in particular age groups. The majority of subtypes need medicine to reduce inflammation and minimize flare-ups.
It is unclear what causes vasculitis exactly. Several subtypes are influenced by genetics. Others happen when the immune system unintentionally attacks blood vessel cells. Possible triggers for this immune system reaction include:
The majority of vasculitis types often manifest the following common signs and symptoms:
In accordance with the body parts affected, other signs and symptoms include:
Tests and procedures include –
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation